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Abstract
Biotin is the major cofactor involved in carbon dioxide metabolism. Indeed, biotin‐dependent enzymes are
ubiquitous in nature and are involved in a myriad of metabolic processes including fatty acid synthesis and
gluconeogenesis. The cofactor, itself, is composed of a ureido ring, a tetrahydrothiophene ring, and a valeric acid

side chain. It is the ureido ring that functions as the CO2 carrier. A complete understanding of biotin‐dependent
enzymes is critically important for translational research in light of the fact that some of these enzymes serve as
targets for anti‐obesity agents, antibiotics, and herbicides. Prior to 1990, however, there was a dearth of
information regarding the molecular architectures of biotin‐dependent enzymes. In recent years there has been
an explosion in the number of three‐dimensional structures reported for these proteins. Here we review our
current understanding of the structures and functions of biotin‐dependent enzymes. In addition, we provide a
critical analysis of what these structures have and have not revealed about biotin‐dependent catalysis.

Introduction
As with many scientific advances, the discovery of biotin (also known as vitamin H or vitamin B7) happened from
a seemingly simply observation; raw egg whites were known to be toxic to humans, and this toxicity could be
prevented by an unknown substance found in egg yolks. In 1936, Kögl and Tönnis reported the discovery and
isolation of the egg yolk factor, which ultimately turned out to be biotin.1 Why then are raw egg whites toxic?
They contain the protein avidin, which essentially binds biotin irreversibly thereby preventing absorption.2 The
structure of biotin [Fig. 1(a)] was subsequently determined in 1942 by Du Vigneaud,3 and in the late 1940s its
role in metabolism was unraveled through a series of elegant studies by Henry Lardy and colleagues who found
that it was required for carboxylation reactions.4 Ten years later the pioneering efforts of Salih Wakil
demonstrated that biotin was covalently attached to acetyl‐CoA carboxylase thus proving it to be an essential
cofactor for enzyme catalysis.5 It is now well established that the primary biological role of biotin is to serve as
an enzymic cofactor required for the transfer of carbon dioxide.

Figure 1 Structure of biotin. The enolate form of the cofactor is shown in (b).
Catalysis by all biotin‐dependent enzymes involves two half‐reactions. Biotin‐dependent enzymes can be divided
into three different classes depending upon whether they function as carboxylases (Class I), decarboxylases
(Class II), or transcarboxylases (Class III). In most cases, biotin‐dependent enzymes catalyze the fixation of
CO2 and thus belong to the Class I family.

The general reactions catalyzed by the Class I enzymes are shown in Scheme 1. Their catalytic mechanisms are
known to proceed through carboxyphosphate intermediates. It is still not entirely clear as to whether
carboxyphosphate decomposes into CO2 and Pi followed by reaction of CO2 with biotin or whether the
carboxylate group is transferred directly from carboxyphosphate to biotin. One intriguing proposal suggests that
the first half reaction involves substrate‐assisted catalysis whereby Pi serves as the general base required to
abstract the N1′ proton from biotin to generate a biotin “enolate‐like” intermediate [Fig. 1(b)].6-8 Indeed, the
nucleophilicity of biotin would be greatly increased by such an abstraction event.
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Scheme 1
As shown in Scheme 1, the first half reaction for a Class I enzyme requires two metal ions, usually magnesium,
for activity. One metal ion is chelated to ATP such that the metal–nucleotide complex is the actual substrate.
The second metal ion binds in the active site separately from the other substrates and because its concentration
does not change over the course of the reaction, it is considered a pseudosubstrate. In the second half‐reaction,
the carboxylate group attached to biotin is transferred to an acceptor molecule residing in a completely
separate active site. The identity of the acceptor gives rise to the name of the enzyme. For example, if pyruvate
is the acceptor then the enzyme is pyruvate carboxylase. Eukaryotic biotin‐dependent enzymes only catalyze
carboxylation reactions. In mammals, the biotin‐dependent enzymes and the metabolic processes they
participate in are as follows: pyruvate carboxylase in gluconeogenesis; propionyl‐CoA carboxylase in odd‐chain
fatty acid oxidation; acetyl‐CoA carboxylase in fatty acid synthesis; and β‐methylcrotonyl‐CoA carboxylase in
amino acid catabolism. There are two additional biotin‐dependent carboxylases not found in eukaryotes: urea
amidolyase, which enables microorganisms to use urea as a nitrogen source and geranyl‐CoA carboxylase, which
is involved in isoprenoid catabolism in microorganisms and plants.
The two half‐reactions catalyzed by the Class II decarboxylases are outlined in Scheme 2. Unlike the
carboxylases, CO2 is not transferred to an acceptor molecule, but instead is released as bicarbonate. There are
three sources of CO2 (designated R in Scheme 2) that can carboxylate biotin and which correspond to the name
of the enzyme: oxaloacetate decarboxylase, methylmalonyl‐CoA decarboxylase, and glutaconyl‐CoA
decarboxylase. These biotin‐dependent decarboxylases are found in anerobic bacteria where they function in
the pumping of sodium ions against a concentration gradient without the use of ATP.
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Scheme 2
Thus far, there is only one Class III family member that has been identified, methylmalonyl CoA‐oxaloacetate
transcarboxylase. It is involved in propionic acid production in the bacterium Propionibacterium shermanii,9 and
it is quite unique in that it does not use free CO2. In addition, neither ATP nor a divalent metal ion is required.
The two half‐reactions for this enzyme are shown in Scheme 3.

E − biotin + methylmalonyl − CoA ⇌ E − biotin − CO−
2 + propionyl − CoA
−
E − biotin − CO2 + pyruvate
⇌
E − biotin + oxaloacetate
Scheme 3

In all three of the reactions outlined in Schemes 1, 2, and 3, biotin is designated as E‐biotin to indicate that the
cofactor is covalently attached to the enzyme. The attachment is made via an amide linkage between the
carboxylate group of the biotin valerate side chain [Fig. 1(a)] and the ε‐amino group of a specific lysine residue.
The formation of the amide bond is a posttranslational modification event that is catalyzed by holocarboxylase
synthase (also known as biotin protein ligase). The specific lysine residue that is modified is contained within the
tetrapeptide sequence Ala‐Met‐Lys‐Met. This sequence is not absolutely invariant, however, because in some of
the urea amidolyases the lysine is contained within the following sequences: Ser‐Met‐Lys‐Met or Ala‐Met‐Lys‐
Ala or Ala‐Met‐Lys‐Thr.10
At present there are more than 70 X‐ray coordinate files deposited in the Protein Data Bank for structures of
biotin‐dependent enzymes. An elegant review focusing on the holoenzyme structures of various biotin‐
dependent carboxylases has recently been published.11 Due to space limitations, however, details concerning
the chemical mechanisms of the individual components were necessarily lacking. This article serves to fill the
gap by describing the structural and functional aspects of the individual components. For a description of the
entire holoenzyme complexes, please see Tong, 2012.11

Overall Structure of a Biotin Carboxylation Domain: The First Half‐Reaction
Acetyl‐CoA carboxylase, a Class I family member, catalyzes the carboxylation of acetyl‐CoA to form malonyl‐CoA.
This reaction constitutes the first committed step in the biosynthesis of long chain fatty acids.12 In Escherichia
coli, the enzyme is composed of three subunits that are isolated separately and that display distinct functional
properties.13 The biotin carboxylase subunit catalyzes the first half reaction (Scheme 1), whereas the
carboxyltransferase subunit carries out the second half reaction. The third component, the biotin carboxyl
carrier protein (BCCP), contains the covalently attached biotin cofactor. BCCP functions as a “swinging arm” that
allows the cofactor to shuttle between the biotin carboxylase and carboxyltransferase subunits of the complex.
The structure of biotin carboxylase from E. coli was reported in 1994, and it represented the first glimpse of a
biotin‐dependent carboxylase.14 A ribbon representation of one subunit of the dimeric enzyme is shown in
Figure 2(a). In this initial structural analysis, a phosphate ion was observed binding in the active site cleft of the
enzyme. As can be seen, the subunit is somewhat asymmetric with a small domain extending away from the
main body of the molecule. Overall the architecture of the enzyme can be envisioned in terms of three domains.
The A‐domain consists of a five‐stranded parallel β‐sheet flanked on either side by a total of four α‐helices.
Following this N‐terminal region is the B‐domain, which contains a three‐stranded anti‐parallel β‐sheet covered
on one side by two α‐helices. The C‐domain is the most complicated of the three regions. It contains an eight‐
stranded antiparallel β‐sheet, a three‐stranded anti‐parallel β‐sheet, and seven α‐helices. The A‐ and B‐domains
are connected by a helix‐turn‐helix motif with the two helices oriented at approximately 90° with respect to one
another. These helices are bridged by Asp 115 which adopts ϕ,Ψ angles of ‐119° and 122°, and this helix‐turn‐
helix motif is a hallmark of proteins belonging to the ATP grasp superfamily as discussed below.

Figure 2 Structure of the E. coli biotin carboxylase. A stereo‐view of one subunit of the enzyme is shown in (a).
The A‐, B‐, and C‐domains are displayed in blue, wheat, and violet, respectively, and the bound phosphate ion is
shown in a sphere representation. The quaternary structure of the enzyme is depicted in (b). The two‐fold
rotational axis relating one subunit to another is nearly perpendicular to the plane of the page. X‐ray
coordinates were obtained from the Protein Data Bank (1BNC). All structure figures were prepared with the
software package PyMOL.94
Shown in Figure 2(b) is a ribbon representation of the biotin carboxylase dimer. The B‐domains for each subunit
are located on opposite edges of the dimer, nearly 90 Å from one another. The subunit–subunit interface is
formed by three α‐helices (two from the A‐ and one from the C‐domain) and a β‐strand‐turn‐β‐strand motif
delineated by Phe 357 to Tyr 372. This strand‐turn‐strand secondary structural element serves to bridge the
eight‐stranded β‐sheets in each C‐domain, thereby forming an approximate 16‐stranded antiparallel β‐sheet
across the dimer interface. Given the evidence that E. coli biotin carboxylase exhibits an extreme form of
negative cooperativity called half‐sites reactivity,15, 16 it is tempting to speculate that the conduit for
communication between the subunits occurs along this 16‐stranded antiparallel β‐sheet.
E. coli biotin carboxylase displays a slow ATPase activity in the absence of biotin or biotinylated‐BCCP. As a
consequence, the structure of the wild‐type enzyme in complex with MgATP alone could not be determined.
However, the structure of an inactive mutant (E288K) protein was co‐crystallized with ATP.17 In this structure,
the B‐domain rotated by ∼45° relative to the A‐ and C‐ domains allowing it to close over the active site cleft
[Fig. 3(a)]. A close‐up view of the ATP binding pocket is provided in Figure 3(b). Key side chains involved in
anchoring the ligand to the protein include Lys 116, Lys 159, Glu 201, His 236, and Lys 288. Further details
concerning the active site pocket are presented below. This “closed” conformation with bound nucleotide has
been subsequently observed in other biotin carboxylases18, 19 as well as in the biotin carboxylase domains of the
pyruvate carboxylases from Staphylococcus aureus and Rhizobium etli cfn42.20-22

Figure 3 Structure of the E. coli biotin carboxylase in complex with ATP. A stereo‐view of one subunit of the
enzyme is presented in (a). The color‐coding is the same as in Figure 2. The bound ATP is depicted in sphere
representation. Note how the B‐domain closes down upon nucleotide binding. Those amino acid residues
important for ATP binding are shown in (b). The structure shown is that of the E288K mutant protein. Potential
hydrogen bonds are indicated by the dashed lines. X‐ray coordinates were obtained from the Protein Data Bank
(1DV2).
One question that arises is whether the B‐domains of the biotin carboxylase dimer are completely splayed open
in the absence of nucleotides. In other words, do these domains only close down upon nucleotide binding? In
the first structure of the E. coli biotin carboxylase, the B‐domains of the dimer were completely open, albeit
several residues in these domains were involved in crystal contacts. The crystal structure of the biotin
carboxylase domain of the Aquifex aeolicus pyruvate carboxylase, however, also showed the B‐domain in an
open conformation.23 In contrast, crystal structures of the apo biotin carboxylase domains from yeast acetyl‐CoA
carboxylase,24 human acetyl‐CoA carboxylase 2,25 and Bacillus thermodenitrificans pyruvate carboxylase26 all
demonstrated conformations for the B‐domains somewhere between the closed and completely open forms.
Recent molecular dynamics studies of E. coli biotin carboxylase suggest that the most stable position for the B‐
domain may not be in the completely open state in the absence of substrate but rather in a partially closed
state.27 Single molecule fluorescence studies will be needed to experimentally confirm the resting positions of
the B‐domains in the absence of substrates.
The solution of the crystal structure of E. coli biotin carboxylase14 in the mid‐1990s turned out to be fortuitous in
that it became one of the charter members (along with glutathione synthetase,28 D‐Ala‐D‐Ala ligase,29 and
succinyl‐CoA synthetase30) in the discovery of the ATP‐grasp superfamily of enzymes.31, 32 Most, but certainly not
all members of this family, catalyze bond formation between a carboxylate and an amino (or thiol) group where
the first step involves the hydrolysis of ATP to activate a carboxylate‐containing substrate and the second step
involves a nucleophilic attack on the carbonyl carbon of the acylphosphate intermediate (Fig. 4). The manner in
which the acylphosphate intermediate is stabilized in the active site of an ATP‐grasp protein is still not well
understood, however.33

Figure 4 General overall reaction of enzymes belonging to the ATP‐grasp superfamily. Most members employ an
acylphosphate intermediate in their reaction mechanisms.
From structural studies, it is now known that all enzymes belonging to the ATP‐grasp superfamily adopt similar
molecular architectures with three major motifs: the N‐terminal, the central, and the C‐terminal regions. These
motifs are also referred to in the literature as the A‐, B‐, and C‐domains as described previously for biotin
carboxylase [Fig. 2(a)]. Typically, the B‐domain in an ATP‐grasp protein contains four strands of antiparallel β‐
sheet flanked on one side by two α‐helices. There is a highly flexible loop, typically glycine and serine rich, which
connects the second and third β‐strands of the B‐domain [Fig. 5(a)]. This so‐called T‐loop, disordered in the
absence of a nucleotide, becomes ordered upon nucleotide binding where it provides hydrogen‐bonding
interactions to the β‐ and γ‐phosphoryl oxygens of the cofactor [Fig. 5(b)].34 The orientation of the B‐domain,
with respect to the rest of the protein, depends upon the presence or absence of bound nucleotide in the
binding cleft. When the nucleotide is present, the B‐domain moves toward the A‐ and C‐terminal regions due to
the interactions of the nucleotide with residues of the T‐loop: hence the name ATP‐grasp. The A‐ and C‐domains
cluster together to provide the substrate‐binding pocket [Fig. 5(c)]. Note that ATP‐grasp proteins do not contain
the canonical “P‐loops” found in such enzymes as adenylate kinase, the G‐proteins, and the myosin motor
domain.35 P‐loops require the consensus sequence of Gly‐X‐X‐X‐X‐Gly‐Lys‐Thr/Ser, and their structures are
essentially insensitive to the presence or absence of ligands. This is in sharp contrast to the T‐loops in the ATP‐
grasp proteins, in which their conformations are dependent upon the presence or absence of nucleotides and
the nature of the moiety occupying the γ‐phosphate position.36 As such, the terminology of “P‐loop” should not
be applied to ATP‐grasp proteins.

Figure 5 Elements of the ATP‐grasp fold. The three‐dimensional structure of PurT‐encoded glycinamide
ribonucleotide transformylase serves as a prototype for ATP‐grasp superfamily members.36, 95 This enzyme,
from E. coli, is involved in the de novo pathway for purine biosynthesis. All ATP‐grasp superfamily members have
B‐domains that change their positions depending upon the presence or absence of bound nucleotides. In
addition, as indicated in (a), they all have a characteristic helix‐turn‐helix motif that connects the A‐ and B‐
domains (light green) and a T‐loop that surrounds the phosphoryl oxygens of the nucleotide triphosphate
(wheat). A close‐up view of the ATP‐binding pocket for glycinamide ribonucleotide transformylase is presented
in (b). One of the residues that interacts with the phosphoryl oxygens, Arg 114, is provided by the helix‐turn‐
helix motif. ATP‐grasp enzymes typically coordinate two magnesium ions with a glutamate residue serving as the
metal bridging ligand. In the case of glycinamide ribonucleotide transformylase, this bridging ligand is Glu 279.
The magnesium ions are depicted as teal spheres. Whereas the B‐domain is intimately involved in nucleotide
binding, the A‐ and C‐domains form a cradle that harbors the side chains responsible for substrate binding,
which for glycinamide ribonucleotide transformylase is glycinamide ribonucleotide (c).

Biotin Carboxylase Domains Bound to Substrates: Insights into Mechanism
Following the initial X‐ray investigations of the E. coli biotin carboxylase, additional structures were
subsequently determined in the presence of various ligands. Taken together these models have provided a
detailed molecular scaffold for understanding the intriguing catalytic mechanism of the enzyme. We will begin
our discussion of these complexes by first focusing on biotin carboxylase with its bound substrates, ATP,
bicarbonate, and biotin, and then turning our attention to the binding modes for its inhibitors.

A variety of biotin carboxylase structures with bound nucleotides or nucleotide analogs have now been
reported.17-19 From these studies, several key interactions between the protein and the nucleotides have been
identified, many of which have been confirmed by site‐directed mutagenesis. Figure 3(b) summarizes the most
important of these interactions. Unless otherwise noted, the following discussion refers to the E. coli enzyme.
The adenine moiety of ATP interacts with a loop of residues delineated by Glu 201 to Leu 204. The exocyclic
amine forms hydrogen bonds with the carboxylate group of Glu 201 and the main chain carbonyl oxygen of Lys
202, whereas the peptidic nitrogen of Leu 204 interacts with N‐1′ of the adenine ring. In addition, Tyr 203
participates in a T‐shaped stacking interaction with the adenine ring. Both Tyr 203 and Leu 204 form part of the
hinge that allows the B‐domain to rotate over the active site.17, 37 In some of the reported structures, the C‐2
hydroxyl group of the ATP ribose lies within hydrogen bonding distance to the side chain of His 209. The
importance of this interaction is underscored by the fact that the H209A mutant protein has a Km for MgATP that
is 70‐fold higher than observed for the wild‐type enzyme.38 It should be noted that the homologous residue to
His 209 in other members of the ATP‐grasp superfamily is a glutamate. Another important active site interaction
occurs between Lys 116 and the oxygens of the α‐ and β‐phosphoryl groups of the nucleotide. Lys 116 lies in the
elbow region of the helix‐turn‐helix motif, which according to molecular dynamics studies, moves towards the
active site upon MgATP binding.27 Mutation of Lys 116 to a glutamine causes a 50‐fold increase in the Km for
MgATP, which further underscores the importance of this residue in ligand binding.38
One of the most important architectural features of the B‐domain is the T‐loop defined by Lys 159 to Met 169
that covers the phosphate groups upon MgATP binding [Fig. 3(b)]. In models of biotin carboxylase with bound
nucleotide, Lys 159 typically interacts with both N‐7 of the purine base and with one of the α‐phosphoryl
oxygens of the nucleotide. Consistent with the X‐ray crystallographic data, mutagenesis of Lys 159 to glutamine
results in almost a 100‐fold increase in the Km for MgATP.38 The T‐loop contains a conserved sequence of amino
acids (Ala‐Ser‐Gly‐Gly‐Gly‐Gly‐Gly‐Arg‐Gly), with the peptidic groups of two of the glycines, Gly 165 and Gly 166,
interacting with a β‐phosphoryl oxygen of the ligand [Fig. 3(b)]. Site‐directed mutagenesis of these two residues
to valines yielded enzymes with 40‐fold increases in the Km for MgATP.39
The biotin carboxylase domains of biotin‐dependent proteins are commonly referred to as “two metal enzymes”
because two metal ions are required for their catalytic activities. The metals used by biotin carboxylases in
vivo are magnesium ions, but at least for the E. coli biotin carboxylase, manganese and cobalt can also support
activity.40 A close‐up view of the coordination spheres surrounding the magnesium ions when bound to the S.
aureus biotin carboxylase is provided in Figure 6(a). This structure was determined in the presence of the non‐
hydrolyzable ATP analog AMPPNP.18 As mentioned previously, one of the metal ions binds to the enzyme as the
metal‐nucleotide chelate. It is not possible to determine which magnesium ion in Figure 6(a) represents the
“metal” in the metal‐nucleotide chelate. However, it should be noted that magnesium is mostly coordinated to
the β‐γ phosphoryl groups of ATP suggesting that magnesium (A) is part of the ATP substrate.41 Both magnesium
ions are octahedrally ligated and bridged by the side chain of Glu 288. Magnesium “A” is surrounded by β‐ and γ‐
phosphoryl oxygens of ATP, the carboxylate side chain of Glu 288 (a bidentate ligand), and two water molecules.
In contrast, magnesium (B) is coordinated by the side chain carboxylate of Glu 274 (a bidentate ligand), oxygen
atoms from the α‐ and γ‐phosphoryl groups, a water molecule, and a carboxylate oxygen contributed by Glu
288. The coordination geometry exhibited by the S. aureus biotin carboxylase has also been observed in the
biotin carboxylase domain of pyruvate carboxylase16 and in other enzymes belonging to the ATP‐grasp
superfamily including carbamoyl phosphate synthetase,42 glycinamide ribonucleotide transformylase,36 and N5‐
carboxyaminoimidazole ribonucleotide synthetase,43, 44 among others.

Figure 6 The binding of MgAMPPNP to the S. aureus biotin carboxylase. Shown in (a) is a close‐up view of the
region surrounding the MgAMPPNP ligand when bound to the enzyme (PDB accession no. 2VPQ). Both
magnesium ions, depicted as gray spheres, display octahedral coordination geometry. Water molecules are
shown as red spheres. The differences in AMPPNP binding, with or without magnesium ions, is shown in (b). The
nucleotide, with its accompanying metal ions, is displayed in violet. Superimposed on this is the conformation of
the nucleotide when it binds into the active site without its accompanying metals (light blue, PDB accession
no. 2J9G).
The role of the metal ions in catalysis is, most likely, to correctly position MgATP into the active site cleft. In the
structure of the E. coli biotin carboxylase complexed with AMPPNP in the absence of metals, the phosphate
chain curls back onto itself.18 This unusual conformation of AMPPNP is in stark contrast to the extended
phosphate chain observed when both magnesium ions are present [Fig. 6(b)]. In addition to the X‐ray structural
data, site‐directed mutagenesis of the two active site residues coordinating the metals, Glu 274 and Glu 288,
results in a 100‐fold decrease in maximal velocity, thus suggesting that any alteration in the positioning of ATP
dramatically affects catalysis.38, 45 In addition to the structural role of the metal ions, there is also a well‐
established kinetic function. Attwood and others have shown that in the biotin carboxylase domain of pyruvate
carboxylase, Mg2+ stabilizes the enzyme‐carboxybiotin complex.8, 46
Thus far, two crystal structures of biotin carboxylase with biotin and ADP have been reported. Chou et
al.,19 described the structure of E. coli biotin carboxylase with bound bicarbonate, free biotin, and ADP, whereas
Lietzan et al.,22 determined the structure of R. etli pyruvate carboxylase with BCCP‐biotin and ADP bound in the
biotin carboxylase domain. In the structure of E. coli biotin carboxylase, bicarbonate is anchored into the active
site through interactions with Arg 292, Glu 296, and Arg 338 [Fig. 7(a)]. On the basis of this model with the fully
loaded active site, it was postulated that Glu 296 functions as an active site base to remove the proton from
bicarbonate. The E296A mutant protein demonstrated only a 10‐fold decrease in the activity; however,19 it was
argued that in the mutant protein a hydroxide ion removes the proton. It is hard to reconcile how the enzyme
generates such a hydroxide ion given the high pK of water. Furthermore, the R292A mutant protein showed no
increase in the Km for bicarbonate, thus calling into question whether the observed bicarbonate‐binding site in
the crystalline protein is an artifact.45 It is also important to note that in the original structure of E. coli biotin
carboxylase, a phosphate, derived from the crystallization buffer, was found in the active site. The phosphate
group also participates in electrostatic interactions with Arg 292, Glu 296, and Arg 338. An overlay of the two

biotin carboxylase complexes demonstrates that the bicarbonate and phosphate ligands lie virtually on top of
one another [Fig. 7(b)]. Interestingly, the structure of the E296A mutant protein reported by Chou et
al.,19 showed a sulfate ion, again derived from the crystallization solution, located in the putative bicarbonate‐
binding site.19 Perhaps the bicarbonate and the phosphate product exchange positions during the course of
catalysis as proposed by Zeczycki et al.7 An alternative explanation, however, is that the observed binding
position for the bicarbonate in the enzyme/biotin/bicarbonate/ADP crystalline complex does not represent the
“true” bicarbonate binding pocket in a productive enzyme complex because ATP and its associated metals are
missing.

Figure 7 The binding of biotin, bicarbonate, and MgADP to the E. coli biotin carboxylase. A stereo‐view of the
biotin carboxylase active site with its bound ligands is shown in (a). Potential hydrogen bonds are indicated by
the dashed lines. An overlay of the structure of biotin carboxylase solved in the presence of biotin, bicarbonate,
and MgADP with that determined only in the presence of inorganic phosphate is shown in (b). The bicarbonate
and phosphate are located in nearly identical positions in the active sites of the two models. X‐ray coordinates
were obtained from the Protein Data Bank (3G8C and 1BNC).
There are additional discrepancies between the X‐ray crystal structure of the fully loaded structure of the E.
coli biotin carboxylase and subsequent solution studies. As can be seen in Figure 7(a), Arg 338 lies within
hydrogen bonding distance to the carbonyl oxygen of the cofactor,19 and it was suggested that it stabilizes the
oxyanion formed during the carboxylation reaction. Two different site‐directed mutagenesis studies targeting
Arg 338 (R338Q, R338S, and R338A)25, 47 found that the Km for biotin does not change, but the maximal velocity
decreases anywhere from 10‐fold to 230‐fold. One investigation reported the Km for ATP increased 63‐fold in the
Arg 338 mutant proteins.47 This same study also demonstrated that these Arg 338 mutant proteins exhibited
negative cooperativity with respect to bicarbonate. Mutations of the homologous arginine in R. etli pyruvate
carboxylase resulted in a 25‐ to 100‐fold decrease in the maximal velocity. Analysis of the biotin carboxylase
domain of R. etli pyruvate carboxylase supports a role for this arginine in stabilizing the biotin enolate in the
enzyme active site and suggests that an additional role may be to prevent the return of carboxybiotin to the
biotin carboxylase domain active site.7, 22 These results are especially intriguing considering that the original
biotin carboxylase structure showed that Arg 338 interacts with phosphate, which binds in the putative
bicarbonate‐binding site. A crystal structure of biotin carboxylase in complex with ATP, bicarbonate, biotin and

two magnesium ions is critically needed in order to reconcile the observed differences between solid state and
solution studies.
The structural analyses of Chou et al.,19 represented significant advances in our understanding of the reaction
mechanism of biotin carboxylase. Nonetheless, in light of the fact that phosphate and sulfate ions can occupy
the “bicarbonate‐binding” site, that the kinetic data on the R292A and E296A mutant proteins do not strongly
support the proposed mechanism, and that the structure reported by Chou et al.,19 contained ADP, not ATP, the
jury is still out regarding the catalytic mechanism of biotin carboxylase. It is possible that the mechanism of
biotin carboxylase proceeds in a manner more similar to that proposed for N5‐carboxyaminoimidazole
ribonucleotide synthetase.44 For this enzyme it is thought that an active site base is not required to deprotonate
bicarbonate. Rather bicarbonate, in its protonated form, reacts with ATP to generate a carboxyphosphate
intermediate, which adopts a pseudochain conformation as suggested by molecular mechanics
calculations.43 According to the proposed mechanism, the carboxyphosphate decomposes to CO2 via an
intramolecular proton abstraction by the phosphate group.44
Recently, the Tong group reported a structure of E. coli biotin carboxylase with two ADP molecules bound in the
active site.48 One nucleotide was in the ATP‐binding site whereas the other one was located in the bicarbonate
and biotin‐binding site. This model was used to explain substrate inhibition by ATP in biotin carboxylase, and the
authors proposed that inhibition by ATP was how the enzyme was regulated.

Biotin Carboxylase Domains Bound to Inhibitors
The very recent discovery of inhibitors to prokaryotic biotin carboxylases represents a classical example of
serendipity. Investigators at Pfizer were screening bacteria against a library composed of inhibitors to tyrosine
protein kinases and found that the pyridopyrimidines [Fig. 8(a)] possess antibacterial activities.49 To identify the
enzymological target of these compounds, resistant strains of Hemophilus influenza were generated, and the
resistance mapped to the gene coding for biotin carboxylase. X‐ray crystallographic and enzyme inhibition
analyses of the pyridopyrimidines showed that they bind in the ATP site and interact with many of the same
residues as the nucleotide, namely the loop of residues between Glu 201 to Leu 204 and Lys 159 [Fig. 8(b)].50

Figure 8 The binding of pyridopyrimidines and aminooxazoles to biotin carboxylase. The chemical structures for
three pyridopyrimidine inhibitors of biotin carboxylase (1, 2, and 3) and one aminooxazole (4) are shown in (a).
The manners in which the pyridopyrimidine inhibitors bind to biotin carboxylase are depicted in stereo in (b).
Compounds 1, 2, and 3 are highlighted in light orange, light green, and light blue, respectively. For comparison
purposes, the conformation of ATP, when bound to biotin carboxylase, is also shown. Compound 4 binds in a
similar orientation to the pyridopyrimidine inhibitors as depicted in (c). X‐ray coordinates were obtained from
the Protein Data Bank (2V58, 2V59, 2V5A, 2W71, and 1DV2).
After validating biotin carboxylase as a target for antibacterial agents, the Pfizer group capitalized on the biotin
carboxylase/pyridopyrimidine structures by conducting virtual screening and fragment‐based drug design to
develop additional classes of inhibitors.51 Figure 8(c) shows an example of one of the biotin carboxylase
inhibitors discovered by this approach. It belongs to the aminooxazole series of compounds, which have
pharmacophore features very similar to the pyridopyrimidines. As expected, these types of inhibitors bind to the
ATP site and utilize similar interactions to anchor to the protein.
At the same time the Pfizer group was working with the pyridopyrimidines and aminooxazole inhibitors,
scientists at Schering‐Plough utilized high‐throughput screening to discover that benzimidazole‐carboxamide
derivatives also inhibit bacterial biotin carboxylases [Fig. 9(a)].52 These types of compounds bind in the ATP
pocket using the same amino acid residues as the pyridopyrimidines and aminooxazoles [Fig. 9(b)].

Figure 9 The binding of inhibitors to biotin carboxylase. The chemical structure of 2‐(2‐chlorobenzylamino)‐1‐
(cyclo‐hexylmethyl)‐1H‐benzo[d]imidazole‐5‐carboxamide is shown in (a). The manner in which this compound
binds to biotin carboxylase is depicted in (b). On the basis of this initial structural analysis, a series of novel
inhibitors was created.52 X‐ray coordinates used were from the Protein Data Bank (3JZF). Soraphen A is a potent
antifungal agent with the chemical structure shown in (c). It binds to yeast biotin carboxylase in a pocket located
at the interface between the N‐ and C‐terminal domains as indicated by the space‐filling representation in (d). X‐
ray coordinates were from the Protein Data Bank (1W96).
Unlike the prokaryotic biotin carboxylases, there is only one inhibitor of eukaryotic biotin carboxylases that has
been identified thus far, which is soraphen A [Fig. 9(c)]. It is a natural product that displays antifungal
activity.53 The structure of yeast biotin carboxylase bound to soraphen A shows that the inhibitor is 25 Å away
from the active site and positioned at the interface between the A‐ and C‐terminal domains [Fig. 9(d)].24 Crystals
of the yeast enzyme, in complex with soraphen A, contain three subunits in the asymmetric unit, and these
subunits demonstrate neither dimeric nor trimeric associations. It is thought that soraphen A functions by
inhibiting dimerization.
Recent structural analyses of the biotin carboxylase domain of human mitochondrial acetyl‐CoA carboxylase
have also shown that soraphen A binds in the same position as that observed for the yeast enzyme.54 The
soraphen A binding site in the human enzyme is also the phosphorylation site used for regulation of its
activity.54, 55 Phosphorylation of the enzyme prevents polymerization of the inactive monomers into the active
long filamentous form. The fact that soraphen A binds in the same site in which phosphorylation occurs suggests
that it inhibits enzyme activity by preventing polymerization.54

Structure of the Biotin Carboxyl Carrier Protein
The ability of the biotin carboxylase and carboxyltransferase components of E. coli acetyl‐CoA carboxylase to use
free biotin as a substrate greatly simplified the analysis of these two enzymes. The fact remains, however, that
biotin is not the natural substrate. In vivo, biotin is covalently attached to the biotin carboxyl carrier protein
(BCCP). In some bacteria (e.g. E. coli) BCCP is a separate protein, whereas in other prokaryotes biotin
carboxylase and BCCP are on a single polypeptide chain. The situation in eukaryotes is completely different;
BCCP is on the same polypeptide chain as the biotin carboxylase and carboxyltransferase functionalities.
Early structural analyses on BCCP focused on the protein from E. coli, which is composed of two domains, the N‐
terminal and C‐terminal. The C‐terminal domain contains biotin covalently attached to a specific lysine (Lys 122).
Before the gene for E. coli BCCP was cloned, conventional purification of BCCP sometimes resulted in proteolytic
cleavage between these two domains. Athappilly and Hendrickson took advantage of this property by purifying
BCCP, cleaving it with subtilisin Carlsberg to generate the biotinylated C‐terminal domain (hereafter referred to
as BCCPsc), and crystallizing it.56 The structure of this C‐terminal domain was solved to a nominal resolution of
1.8 Å.
As can be seen in Figure 10, the structure of the biotinylated C‐terminal domain consists of two four‐stranded
antiparallel β‐sheets arranged around an approximate two‐fold rotational axis. The α‐carbons for the two halves
superimpose with a root‐mean‐square deviation of 0.52 Å.56 The lysine residue to which biotin is attached is
located in a loop connecting two of the β‐strands. The C‐terminal domain of E. coli BCCP also contains a “thumb‐
like” structural motif lying near the biotin moiety. This thumb contains Thr 94 with its side and main chain
oxygen atoms lying within ∼3 Å of the carbonyl oxygen and N1′ of biotin, respectively. On the basis of these
distances, it was proposed that Thr 94 forms hydrogen‐bonding interactions with biotin.

Figure 10 The molecular architecture of the C‐terminal domain of the E. coli BCCP. The protein is characterized
by two layers of antiparallel β‐sheet, highlighted in blue and green. Presumed hydrogen bonds between Thr 94
and biotin are indicated by the dashed lines. Subsequent NMR studies suggest that these hydrogen bonds do not
occur. X‐ray coordinates were from the Protein Data Bank (1BDO).
At the same time the crystal structure of the biotinylated C‐terminal domain of E. coli BCCP was published, John
Wallace and coworkers reported the cloning, overexpression, and purification of the BCCP C‐domain containing
87 rather than 80 residues (hereafter referred to as BCCP87).57 BCCP87 was found to be an excellent substrate
for both biotin carboxylase and carboxyltransferase,58 and its small size made it amenable to a structural analysis
by NMR.59 Not surprisingly, the NMR structures of both the apo and holo forms of BCCP87 were very similar to
the crystal structure of BCCPsc with a few notable exceptions.60 Most importantly, solvent deuterium exchange
experiments revealed that Thr 94 does not, in fact, form hydrogen bonds with the N1′ of biotin as originally

proposed.56 Several NOEs (i.e., interactions) were detected, however, between the biotin moiety and the amino
acid residues in the “thumb‐like” region. Most likely, these residues serve to immobilize the biotin cofactor.
In contrast to the three‐dimensional structure of the biotinoyl domain of E. coli BCCP, the structures of the
biotin containing 1.3S subunit of transcarboxylase61 and the biotinoyl domain of human acetyl‐CoA
carboxylase62 do not contain the “thumb‐like” motif. Yet, their overall folds are very similar to that of E.
coli BCCP. Because both proteins are small, NMR was used to determine their structures, thus allowing their
dynamical properties to be analyzed. Unlike E. coli BCCP87, no NOEs between the biotin moiety and the protein
were detected in either protein. Given that both the 1.3S subunit of transcarboxylase and the biotinoyl domain
of human acetyl‐CoA carboxylase appear to function quite well without a “thumb,” the question arises as to the
role of this motif in the E. coli BCCP. Mutations in this region of the E. coli BCCP were found to impair the growth
of the bacterium suggesting that it is important for the function of the protein, but the chemical mechanism for
this phenotype is not understood.63 In order to address the role of this motif, Weaver et al.,64 modeled holo
BCCP87 onto the structure of biotin carboxylase with ATP bound and proposed that the major point of contact
was between a β‐strand in BCCP87 (Gln 122 to Gln 126) and a β‐strand in the B‐domain of biotin carboxylase
(Gly 168 to Val 172). Whether this modeling is correct or not will have to await additional structural studies of
BCCP bound to biotin carboxylase and carboxyltransferase.

Carboxyltransferase Domains with the Crotonase Fold
Any discussion of the carboxyltransferase domain structure must necessarily be given in context of the
biochemical problem that the enzyme has to solve. The major chemical hurdle in the second half‐reaction of
biotin‐dependent enzymes is the stabilization of enolate anions. For instance, in the Class I carboxylases, CO2 is
transferred from carboxybiotin to an acceptor molecule. As shown in Scheme 4, this transfer requires an enolate
anion in the acceptor molecule as well as an enolate‐like anion in biotin. Since enolate anions abound in
biochemical systems, one particular strategy that nature has evolved utilizes two hydrogen bonds from peptidic
NH groups to stabilize oxyanion moieties. These peptidic NH groups form an “oxyanion” hole. One such protein
scaffold that correctly juxtaposes peptidic NH groups to form an oxyanion hole is referred to as a crotonase (or
enoyl‐CoA hydratase) fold after the enzyme for which it was first described.65, 66 Members of the crotonase
superfamily contain a core domain of repeated ββα motifs that form two parallel β‐sheets situated at 90° with
respect to each other. These β‐sheets are surrounded by α‐helices. A ribbon representation of enoyl‐CoA
hydratase, the founding member of the superfamily, is displayed in Figure 11(a). One of the two residues
providing the peptidic NH groups for the oxyanion hole is positioned at the N‐terminus of an α‐helix, and it is
thought that the positive charge of the helix dipole also contributes to transition‐state stabilization [Fig. 11(b)].

Figure 11 The structure of enoyl CoA hydratase. Members of the crotonase superfamily typically display either
trimeric or hexameric quaternary structures with their active sites wedged between subunits. Shown in (a) is a
ribbon representation of one subunit of enoyl CoA hydratase, an enzyme that catalyzes the second step in fatty
acid oxidation. X‐ray coordinates were from the Protein Data Bank (2DUB).77 The subunit can be envisioned in
terms of two domains. The N‐terminal region is dominated by two layers of β‐sheet (displayed in blue and
magenta), whereas the C‐terminal motif contains three α‐helical regions (all α‐helices are shown in green).
Members of the crotonase superfamily contain an oxyanion hole, which is formed by two peptidic nitrogen
groups (b). Also, in these family members, it is thought that a helix dipole moment plays a role in activating the
carbonyl carbons of the substrates for nucleophilic attacks.

Scheme 4
The carboxyltransferase domains of biotin‐dependent enzymes must stabilize enolate anions in both substrates.
It is thus not surprising that their three‐dimensional structures are composed of homologous domains (or
polypeptide chains depending upon the protein being discussed). These domains have the crotonase fold, and
they form the basic architectural element for the various quaternary structures described below. Indeed, from
the following descriptions, it is clear that nature started with the crotonase fold, and then evolved it into ever
more complex quaternary structural arrangements.

E. Coli and S. Aureus Carboxyltransferases
The carboxyltransferase domains of the E. coli and S. aureus acetyl‐CoA carboxylases are α2β2 heterotetramers
[Fig. 12(a)].67 Although the crystal structures were solved in the absence of bound substrates, site‐directed
mutagenesis and solution studies indicate that the α‐subunits bind biotinylated‐BCCP, whereas the β‐subunits
bind acetyl‐CoA. The active sites lie at the interfaces between the α,β dimers [Fig. 12(a)]. In addition, both the α‐
and β‐subunits have a crotonase‐like fold, thus suggesting that the genes encoding them arose from a
duplication event.

Figure 12 The structure of the E. coli carboxyltransferase. The quaternary structure of the enzyme is an
α2,β2 heterodimer. X‐ray coordinates were from the Protein Data Bank (2F9Y). The α‐ and β‐chains are colored in
light blue and pink, respectively in (a). The view shown is looking down the twofold rotational axis that relates
one α,β dimer to another. Each β‐subunit contains a four‐cysteine zinc finger as shown in (b).
The crystal structures of the E. coli and S. aureus carboxyltransferases revealed an unexpected feature not
observed in other carboxyltransferases, namely a four‐cysteine zinc finger domain on the N‐terminus of the β‐
subunit [Fig. 12(b)].67 The zinc finger is part of a saddle‐like motif that is characterized by a patch of amino acids
with a positive electrostatic surface potential. The rest of the protein has an overall negative electrostatic
surface potential.67 Zinc finger domains are commonly associated with proteins that bind nucleic acids, and,
indeed, the E. coli and S. aureus carboxyltransferases were subsequently shown to bind DNA and RNA.68, 69 Using
electrophoretic mobility shift assays, it was demonstrated that the E. coli carboxyltransferase specifically binds
to the mRNA molecules encoding the α‐ and β‐subunits, and this binding results in the inhibition of translation.
In addition, the acetyl‐CoA substrate was shown to compete with the two mRNA molecules for binding to
carboxyltransferase.70 These findings led to an intriguing model for a negative feedback loop in the regulation of
carboxyltransferase activity and ultimately for the regulation of fatty acid biosynthesis in E. coli.70, 71 Briefly, in
stationary phase, when acetyl‐CoA levels are low, carboxyltransferase acts as a “dimmer switch” by binding to
the mRNA coding for the α and β subunits and inhibiting translation as well as enzymatic activity. In contrast,
during log phase the high concentration of acetyl‐CoA competes with mRNA for binding to carboxyltransferase,
thereby allowing catalysis to occur as well as translation of mRNA to synthesize more carboxyltransferase.

Yeast Carboxyltransferase and the α‐Subunit of Glutaconyl‐CoA
Decarboxylase
The carboxyltransferase component of acetyl‐CoA carboxylase from yeast is a dimer with each monomer
consisting of two domains [Fig. 13(a)]. The crystal structure showed that the N‐terminal domain contained CoA
and therefore is most likely to bind the substrate acetyl‐CoA, whereas the C‐terminal domain binds the biotin
substrate.72 Thus, the eukaryotic version of the carboxyltransferase subunit appears to be a fusion of the α‐ and
β‐subunits of the prokaryotic carboxyltransferase. The two monomers of the yeast enzyme are arranged in a
head‐to‐tail arrangement such that the active site is at the interface between the N‐terminal domain of one
monomer and the C‐terminal domain of another monomer [Fig. 13(a)].

Figure 13 The carboxyltransferase domain of yeast acetyl‐CoA carboxylase and the α‐subunit of glutaconyl‐CoA
decarboxylase demonstrate similar quaternary structures. Both function as homodimers. Shown in (a) is the
carboxyltransferase of the yeast acetyl‐CoA carboxylase. X‐ray coordinates were from the Protein Data Bank
(1OD2). Each subunit of the homodimer can be envisioned in terms of an N‐terminal and a C‐terminal domain,
displayed in pink and blue, respectively. Likewise, the two α‐subunits of the glutaconyl‐CoA decarboxylase dimer
adopt similar bilobal type architectures. The N‐ and C‐terminal domains are depicted in pink and blue,
respectively. X‐ray coordinates were from the Protein Data Bank (1PIX).
A similar type of quaternary structure has also been observed in the α‐subunit of glutaconyl‐CoA decarboxylase
from Acidaminococcus fermentans.73 This subunit catalyzes the first reaction in Scheme 2 where CO2 is
transferred from glutaconyl‐CoA to biotin. As in the yeast carboxyltransferase, the α‐subunit of glutaconyl‐CoA
decarboxylase functions as a homodimer with each monomer containing two crotonase‐like domains. Each
domain binds one of the two substrates. The two monomers are also arranged in a head‐to‐tail fashion with the
active sites lying at the interfaces between the N‐terminal and C‐terminal domains of adjacent monomers
[Fig. 13(b)].

Transcarboxylase 12S Subunit and the β‐Subunit of Propionyl‐CoA
Carboxylase
The quaternary structures of the transcarboxylase 12S subunit from P. shermanii74 and the β‐subunit of
propionyl‐CoA carboxylase from Streptomyces coelicolor75 take the homodimeric structures found in yeast
carboxyltransferase and glutaconyl‐CoA decarboxylase and expand them into hexameric structures, which can
be thought of as either trimers of dimers or dimers of trimers [Fig. 14(a,b)]. Each monomer in these two
enzymes has two domains where the N‐terminal region binds methylmalonyl‐CoA for the transcarboxylase 12S
subunit or propionyl‐CoA for propionyl‐CoA carboxylase and the C‐terminal motif binds biotin. Like all the other
carboxyltransferases discussed so far, both domains have a crotonase type fold. Each dimeric pair is oriented in
a head‐to‐tail manner so that the active sites reside at the interface between opposing N‐ and C‐terminal
domains contributed by different monomers. Other enzymes in the crotonase superfamily also form hexamers
with the same 32 symmetry observed in the transcarboxylase 12S subunit and the β‐subunit of propionyl‐CoA
carboxylase. These include methylmalonyl‐CoA decarboxylase,76 enoyl‐CoA hydratase (crotonase),77 and dienoyl‐
CoA isomerase.78

Figure 14 The transcarboxylase 12S subunit shows a hexameric quaternary structure. The quaternary structure
of the enzyme can be envisioned as a dimer of trimers. X‐ray coordinates were from the Protein Data Bank
(1ON3). The trimer is shown in (a) with the methylmalonyl‐CoA ligands displayed in sphere representations.
Each monomer consists of an N‐ and a C‐terminal domain, colored in pink and blue, respectively. The complete
hexamer is shown in (b).
The transcarboxylase 12S subunit and the β‐subunit of propionyl‐CoA carboxylase are simply larger oligomeric
assemblies of the basic didomain homodimeric structures observed for yeast carboxyltransferase and
glutaconyl‐CoA decarboxylase. One might ask why the latter two enzymes do not form such hexamers. It is a
function of the extra four α‐helices found at their C‐termini. These α‐helices, which are absent in the
transcarboxylase 12S subunit and the β‐subunit of propionyl‐CoA carboxylase, prevent the formation of
hexameric quaternary structures.

Active Site Architecture and Substrate Binding
Given the number of carboxyltransferase subunit or domain structures now solved, there is still a decided lack of
three‐dimensional information regarding the manner in which substrates bind to these enzymes. The structure
of the yeast carboxyltransferase domain of acetyl‐CoA carboxylase contained CoA, whereas the 12S subunit of
transcarboxylase had bound methylmalonyl‐CoA.72, 74 The best characterized, with respect to three‐dimensional
architecture, is the β‐subunit of propionyl‐CoA carboxylase from S. coelicolor in which the binding pockets for
both propionyl CoA and biotin have been identified.75
In all of these enzymes, the acyl‐CoA/CoA ligands bind in bent or U‐shaped conformations with their carbonyl
oxygens residing in oxyanion holes. For the 12S subunit of transcarboxylase, the carbonyl oxygen of
methylmalonyl‐CoA, and by inference its enolate ion, forms hydrogen bonds to the peptidic NH group of Ala 143
and a water molecule [Fig. 15(a)].74 The water molecule is held in place via hydrogen bonds to the peptidic NH
group of Ala 183 and the main chain carbonyl oxygen of Ala 180. The oxyanion hole of the β‐subunit of
propionyl‐CoA carboxylase is somewhat different. It is formed by the peptidic NH group of Gly 183
[Fig. 15(b)].75 In addition, the carbonyl oxygen of propionyl‐CoA lies within 3.2 Å of N‐1′ of biotin.

Figure 15 Oxyanion holes in carboxyltransferases. In the 12S subunit of transcarboxylase, the oxyanion hole is
formed by the backbone amide group of Ala 143 and a water molecule as depicted in (a). X‐ray coordinates were
from the Protein Data Bank (1ON3). In contrast, in the β‐subunit of propionyl‐CoA carboxylase, one backbone
amide group forms the oxyanion hole as shown in (b). X‐ray coordinates were from the Protein Data Bank

(1XNY). The oxyanion hole in propionyl‐CoA carboxylase is formed by the backbone amide group of Ala 420 and
the positive end of a helix dipole moment. X‐ray coordinates were from the Protein Data Bank (1XNY).
The structure of the β‐subunit of propionyl‐CoA carboxylase was especially informative because it contained
biotin bound in the active site.75 The biotin‐binding site is lined with hydrophobic residues, which as pointed out
by Diacovich et al., is very similar to the hydrophobic and van der Waals interactions observed between biotin
and streptavidin.74 The carbonyl oxygen of the ureido ring binds in an oxyanion hole, which is formed by the
peptidic NH group of Ala 420 and the positive end of a helix dipole moment [Fig. 15(c)]. This oxyanion hole helps
to stabilize the ureido (or enolate like) anion of biotin that forms upon decarboxylation.
The structure of the β‐subunit of propionyl‐CoA carboxylase liganded to both substrates allowed Diacovich et
al.,75 to propose a catalytic mechanism for the enzyme that by inference is applicable to other
carboxyltransferase subunits (Fig. 16). The first step in the mechanism involves the decarboxylation of
carboxybiotin to form CO2 and the ureido anion (enolate‐like) of biotin, which is stabilized by an oxyanion hole.
The ureido anion then acts as a base to abstract the proton from propionyl‐CoA to generate an enolate, which is
also stabilized by an oxyanion hole. The enolate anion of propionyl‐CoA subsequently attacks CO2 to form
methylmalonyl‐CoA. It is important to note that this mechanism is very similar to that previously proposed by
Wendt et al., for glutaconyl‐CoA decarboxylase73 and endorsed by Zhang et al., for yeast acetyl‐CoA
carboxylase.72 Accordingly, for the 12S subunit of the transcarboxylase and the β‐subunit of propionyl‐CoA
carboxylase, it is the ureido anion of biotin that serves as the base required to abstract the proton from the α‐
carbon of the thioester substrate. In the case of glutaconyl‐CoA decarboxylase, biotin serves as the acid to
protonate the CO2 donor. The use of the ureido anion as a catalytic base is in direct contrast to other enzymes in
the crotonase superfamily, which utilize either an acidic residue (glutamic or aspartic acid) or a basic residue
(histidine or lysine).66 It is important to keep in mind that the mechanism presented in Figure 16 represents a
starting point for subsequent investigations rather than the final word.

Figure 16 Possible reaction mechanism for propionyl‐CoA carboxylase.

Inhibitors of Carboxyltransferase
Fatty acid synthesis plays a key role in both membrane biogenesis and energy storage. As such, the
carboxyltransferase of acetyl‐CoA carboxylase has been and will continue to serve as a target for herbicides,
antibiotics, and anti‐obesity agents. In fact, several compounds are already commercially available as herbicides
that inhibit the carboxyltransferase component of acetyl‐CoA carboxylase.
Plants have two isoforms of the enzyme. The cytosolic isoform is like the eukaryotic form in that it is a single
polypeptide with multiple domains corresponding to the two enzymatic activities (biotin carboxylase and
carboxyltransferase) and the biotin carboxyl carrier protein. In contrast, the acetyl‐CoA carboxylase in
chloroplasts in dicots is similar to the bacterial enzyme where the two enzymatic functions and the biotin
carboxyl carrier protein reside on separate polypeptide chains. This is in keeping with the hypothesis that
chloroplasts evolved from a symbiotic relationship between plants and bacteria. Chloroplasts from grasses have
the multidomain form found in the cytosol.
At present, three different classes of herbicides that inhibit the carboxyltransferase domain of chloroplast
acetyl‐CoA carboxylase from grasses have been identified: the aryloxyphenoxypropionates (e.g., haloxyfop); the
cyclohexandiones (e.g., tepraloxydim); and the phenylpyrazolines (e.g., pinoxaden). Using the yeast
carboxyltransferase domain of acetyl‐CoA carboxylase as a model for the plant enzyme, Tong and colleagues
determined its structure bound to molecules belonging to each class of herbicide. All of the herbicides bind in

the active site at the interface between the N‐terminal domain of one subunit and the C‐terminal domain of a
neighboring monomer, and all block the acetyl‐CoA binding site.79-81 Obstructing the acetyl‐CoA binding site is
consistent with the observed competitive inhibition versus the product malonyl‐CoA.72 Earlier kinetic analyses
with the aryloxyphenoxypropionates and the cyclohexandiones showed noncompetitive inhibition with respect
to acetyl‐CoA.82 All of the crystal structures revealed that the herbicides share three common anchoring points.
The first two are the peptidic NH groups of Ala 1627 and Ile 1735 that interact with oxygens on the inhibitors. It
is thought that these residues form the oxyanion hole that stabilizes the enolate of acetyl‐CoA during catalysis.
The third is Leu 1705, which participates in a hydrophobic interaction with the herbicides. The significance of
this interaction is underscored by the fact that mutation of Leu 1705 is often observed in plants resistant to the
herbicides.81
In addition to serving as herbicide targets, acetyl‐CoA carboxylase has recently been implicated in anti‐obesity
agents, and molecules that inhibit its carboxyltransferase component are being actively investigated. Humans,
like plants, have two isoforms of acetyl‐CoA carboxylase. One isoform is located in the cytosol and is required for
fatty acid biosynthesis. The other isoform is found in the mitochondria, and it is involved in the regulation of
fatty acid oxidation by using the product of the reaction, malonyl‐CoA, to inhibit carnitine palmitoyl transferase
I. Strikingly, mice, in which the gene encoding the mitochondrial isoform of acetyl‐CoA carboxylase has been
knocked out demonstrate increased levels of fatty acid oxidation resulting in a lean body mass despite
consuming a high fat diet.83 Indeed, the mouse studies provide strong evidence that the mitochondrial isoform
of acetyl‐CoA carboxylase could serve as an ideal target for anti‐obesity agents.
Using high‐throughput screening, scientists at Pfizer discovered a molecule (CP‐640186) that inhibits both
isoforms of mammalian acetyl‐CoA carboxylase.84 In animal models, CP‐640186 decreases fatty acid synthesis
while increasing fatty acid oxidation ultimately leading to a reduction in both body fat and weight. Subsequent
structural analysis of a complex between the yeast carboxyltransferase domain and CP‐640186 showed that the
inhibitor binds at the interface of the carboxyltransferase dimer, and it was concluded that this is also the biotin‐
binding site.85 It should be noted, however, that a kinetic analysis of the inhibitor binding versus biotin was not
reported, and thus the proposed biotin‐binding site is still open to discussion.
Whereas the yeast carboxyltransferase model certainly can be employed as a molecular template for the human
enzyme, the fact remains that successful structure‐based drug design ultimately requires a detailed
understanding of the human enzyme. To this end, scientists at Pfizer, unable to crystallize the human enzyme,
mutated nine active site residues in the yeast carboxyltransferase to the corresponding amino acid residues
found in the human carboyxltransferase. This variant form of the yeast enzyme was found to bind CP‐640186
similarly to that observed in the wild‐type yeast carboxyltransferase domain.86 The investigators at
GlaxoSmithKline were more fortunate in that they were able to crystallize the human carboxyltransferase
domain of acetyl‐CoA carboxylase in complex with CP‐640186 and also found that the inhibitor binds in a similar
manner.87 More importantly, however, their crystal structure revealed that the human enzyme has three
additional α‐helices on the C‐terminus not present in the yeast carboxyltransferase. Subsequent studies of
variant enzymes with the three α‐helices deleted showed them to be important for inhibitor binding.87 Finally, it
should be noted that compounds belonging to the spirochromanones class of molecules, which are structural
analogs of CP‐640186, were found to inhibit both isoforms of human carboxyltransferase.88 Crystal structures of
these inhibitors bound to either the carboxyltransferase domain of yeast acetyl‐CoA carboxylase or the yeast
nine‐residue variant version demonstrated that these inhibitors likewise bind in the same site as CP‐640186.86

Carboxyltransferase Domains without a Crotonase Fold
The carboxyltransferase domains with crotonase folds, as described above, act to carboxylate/decarboxylate
thioesters by stabilizing the developing negative charge of the enolate using an oxyanion hole.

Carboxyltransferase domains from a second sub‐group of biotin‐dependent enzymes, however, do not act on
thioester substrates and do not exhibit a crotonase fold. Specifically these enzymes function on keto acid
(pyruvate/oxaloacetate) and carbamide (urea) substrates. The enzymes in this sub‐group include proteins from
all three classes: pyruvate carboxylase (Class I), the α‐subunit of the Na+ pump oxaloacetate decarboxylase (α‐
OADC; Class II), the 5S subunit of transcarboxylase (5sTC; Class III), and urea amidolyase (Class I). Phylogenetic
analyses of the carboxyltransferase domains of bacterial pyruvate carboxylase and α‐OADC indicate that these
proteins are evolutionarily distinct from the acyl‐CoA carboxylases.89 Urea amidolyase is different from all other
enzymes of this family and appears to be a recently evolved biotin‐dependent enzyme present in only a subset
of bacteria, algae, and fungi.89, 90 Structures of the carboxyltransferase domains of pyruvate carboxylase, α‐
OADC, 5sTC, and urea amidolyase have been reported, revealing that catalysis in this sub‐group does not utilize
an oxyanion hole to stabilize either biotin or the keto acid substrate. As such the exact mechanism by which the
keto acid enolate is stabilized is unclear at the present time.10, 20, 21, 91, 92 It is possible that stabilization of the keto
acid enolate is achieved through a combination of metal ion coordination and/or interaction with an Arg/Gln
side chain pair. It is also possible that these enzymes stabilize the biotin enolate through tetrahedral
coordination of the ureido oxygen.93

Summary
Since that first structure report of a biotin‐dependent carboxylase nearly 18 years ago, enormous progress has
been made in our understanding of these intriguing enzymes. The goal of this review was not to simply provide
descriptions of the biotin carboxylase and carboxyltransferase structures, but rather to critically evaluate what
they have and have not revealed about biotin‐dependent catalysis. Clearly, there are many unanswered
questions, and much research remains. In the end, a thorough understanding of biotin‐dependent enzymes is
not only important from a basic science perspective but also from a translation approach given that some of
these enzymes are targets for the development of anti‐obesity agents, antibiotics, and herbicides. Lastly, with
the rapidly increasing levels of atmospheric CO2 there will be a critical need for the development of catalysts
that can fix CO2 to form C―C bonds. The knowledge gained from a thorough understanding of biotin‐dependent
catalysis will undoubtedly play a key role in the process.
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